Application no. and date | 07788861.8 (espacenet) (Federated) (European Patent Register), 20070611 | Patent/reg. no. and date | DK/EP 2037956, 20121212 | Publication date | 20090325 | Priority no. and date | FR 0605368, 20060616 | EP pub. no. and date |
EP 2037956 20090325 | Effective date | | Applicant/owner | IPSEN PHARMA, 65 Quai Georges Gorse
92100 Boulogne-Billancourt, FR | Applicant ref. no. | P81300102DK00E | Inventor | CHABRIER DE LASSAUNIERE, Pierre-Etienne, 134, quai Louis Blériot
75016 Paris, FR, AUGUET, Michel, 29, rue de la Butte de Rheims
91120 Palaiseau, FR, FAVRE, Christine, 34 rue de Bourguignette
91530 Saint Maurice Montcouronne, FR | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 38/48 (2006.01) , A61P 17/00 (2006.01) , A61P 29/00 (2006.01) | Title | Samtidig, separat eller sekventiel terapeutisk anvendelse af mindst én botulinum neurotoxin og mindst ét opiatderivat | Int. application no. | FR2007000956 | Int. publication no. | WO2007144493 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|